ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Stromelysin-1 (matrix metalloproteinase-3) is a member of the matrix metalloproteinase family. Regulation of its gene expression is critical for tissue homeostasis. Patterns of increased co-expression of stromelysin-1 and ETS-1 genes have been observed in pathological processes. Stromelysin-1 promoter is transactivated by ETS proteins through two palindromic head to head ETS-binding sites, an unusual configuration among metalloproteinase promoters. By using surface plasmon resonance, electrophoretic mobility shift assay, and photo-cross-linking, we showed that full-length human ETS-1 (p51) binds cooperatively to the ETS-binding site palindrome of the human stromelysin-1 promoter, with facilitated binding of the second ETS-1 molecule to form an ETS-1.DNA.ETS-1 ternary complex. The study of N-terminal deletion mutants allowed us to conclude that cooperative binding implied autoinhibition counteraction, requiring the 245-330-residue region of the protein that is encoded by exon VII of the gene. This region was deleted in the natural p42 isoform of ETS-1, which was unable to bind cooperatively to the palindrome. Transient transfection experiments showed a good correlation between DNA binding and promoter transactivation for p51. In contrast, p42 showed a poorer transactivation, reinforcing the significance of cooperative binding for full transactivation. It is the first time that ETS-1 was shown to be able to counteract its own autoinhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cooperativity of dimerization is the same 10-fold effect as autoinhibition, suggesting that the dimer configuration may counteract autoinhibition (167).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Matrix metalloproteinases: effectors of development and normal physiology
Vu, T. H., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.815400 · Cited by 1,235
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Fancy, D. A., & Kodadek, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6020 · Cited by 576
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Cytokine regulation of metalloproteinase gene expression
Mauviel, A. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530404 · Cited by 432
Wasylyk, C., Gutman, A., Nicholson, R., & Wasylyk, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08053.x · Cited by 368
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Research works printed but not linked: 9
- Liu, Z., Ivanoff, A., and Klominek, J. (2001) Int. J. Cancer 91, 638 -643 · DOI · Paper page
- Dittmer, J., and Nordheim, A. (1998) Biochim. Biophys. Acta 1377, F1-F11
- Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M. B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. (1994) Cancer Res. 54, 5683-5688
- Seth, A., Robinson, L., Thompson, D. M., Watson, D. K., and Papas, T. S. (1993) Oncogene 8, 1783-1790
- Venanzoni, M. C., Robinson, L. R., Hodge, D. R., Kola, I., and Seth, A. (1996) Oncogene 12, 1199 -1204
- Buttice, G., Duterque-Coquillaud, M., Basuyaux, J. P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996) Oncogene 13, 2297-2306
- Hodge, D. R., Robinson, L., Watson, D., Lautenberger, J., Zhang, X. K., Venanzoni, M., and Seth, A. (1996) Oncogene 12, 11-18
- Higashino, F., Yoshida, K., Noumi, T., Seiki, M., and Fujinaga, K. (1995) Oncogene 10, 1461-1463
- Cowley, D. O. (2000) Regulation of Transcription Factors ETS-1 and ETS-2 by Autoinhibition and Phosphorylation, Ph.D. dissertation, University of Utah
Cited by
Dittmer, J. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-29 · Cited by 509
“In the presence of a palindromic Ets binding site, the exon VII domain also mediates homodimerization of Ets1 proteins [61].”
Survey of the year 2003 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.726 · Cited by 505
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“The cooperativity of dimerization is the same 10-fold effect as autoinhibition, suggesting that the dimer configuration may counteract autoinhibition (167).”
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Massie, C. E., Adryan, B., Barbosa‐Morais, N. L., Lynch, A. G., Tran, M. G., Neal, D. E., & Mills, I. G. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401046 · Cited by 259
“The pSG5–ETS1 expression construct was a kind gift from Dr A. Bègue (Baillat et al, 2002).”
MethodVariable Control of Ets-1 DNA Binding by Multiple Phosphates in an Unstructured Region
Pufall, M. A., Lee, G. M., Nelson, M. L., Kang, H.-S., Velyvis, A., Kay, L. E., McIntosh, L. P., & Graves, B. J. (2005) · Science · doi:10.1126/science.1111915 · Cited by 246
Review of Ets1 structure, function, and roles in immunity
Garrett-Sinha, L. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1243-7 · Cited by 213
The role of the transcription factor Ets1 in carcinoma
Dittmer, J. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.010 · Cited by 212
Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G., & Keyse, S. M. (2008) · Biochemical Journal · doi:10.1042/bj20071512 · Cited by 195
Kasahara, K., Fukuda, I., & Nakamura, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112419 · Cited by 172
Analysis of Protein–DNA Interactions Using Surface Plasmon Resonance
Majka, J., & Speck, C. (2006) · Springer eBooks · doi:10.1007/10_026 · Cited by 131
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Bitan, G. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13012-8 · Cited by 99
“PICUP also has been applied successfully to characterization of protein‐ligand interactions, including mapping the interaction of signal recognition particle (SRP) with various signal sequences (Cleverley and Gierasch, 2002), binding of the transcription factor ETS‐1 to stromelysin‐1 promoter (Baillat et al., 2002), a…”
MethodA survey of the year 2002 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.649 · Cited by 101
Son, O., Hur, Y., Kim, Y.-K., Lee, H., Kim, S., Kim, M., Nam, K. H., Lee, M.-S., Kim, B.-Y., Park, J., et al. (2010) · Plant and Cell Physiology · doi:10.1093/pcp/pcq108 · Cited by 100
“We have checked possible direct binding of ATHB12 to the promoter or the first intron of GA20ox1 by gel shift assays and surface plasmon resonance techniques (Baillat et al. 2002).”
MethodMix, K. S., Attur, M. G., Al-Mussawir, H., Abramson, S. B., Brinckerhoff, C., & Murphy, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608327200 · Cited by 72
Regulation of the transcription factor Ets‐1 by DNA‐mediated homo‐dimerization
Lamber, E. P., Vanhille, L., Textor, L. C., Качалова, Г. С., Sieweke, M. H., & Wilmanns, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.117 · Cited by 70
“…promoters, comparison of two Ets-1 isoforms, p51 and p42, revealed that the region encoded by exon VII (245–330, lacking in p42 isoform) is required for recruitment of a second Ets-1 molecule, leading to cooperative binding and transactivation of the stromelysin-1 promoter (Baillat et al, 2002).”
BackgroundMethodResultInfluentialLee, G. M., Pufall, M. A., Meeker, C. A., Kang, H.-S., Graves, B. J., & McIntosh, L. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.064 · Cited by 58
Laitem, C., Leprivier, G., Choul‐li, S., Begue, A., Monté, D., Larsimont, D., Dumont, P., Duterque‐Coquillaud, M., & Aumercier, M. (2009) · Oncogene · doi:10.1038/onc.2009.72 · Cited by 63
“Oncogene (2009) 28, 2087–2099 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc EBS palindrome, thereby forming an Ets-1/DNA/Ets-1 ternary complex, which is critical for full transactivation (Baillat et al., 2002).”
BackgroundMethodSelf-citationSP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion
Yordy, J. S., Li, R., Sementchenko, V. I., Pei, H., Muise‐Helmericks, R. C., & Watson, D. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207891 · Cited by 55
“The MMP3 promoter contains palindromic EBS, both of which are essential for activation (Wasylyk et al., 1991; Baillat et al., 2002), while both the uPA and MMP1 promoters contain single EBS.”
BackgroundKato, T., Fujita, Y., Nakane, K., Kojima, T., 義則, 野., Deguchi, T., & Ito, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.047 · Cited by 54
Structural basis of Ets1 activation by Runx1
Shrivastava, T., Mino, K., Babayeva, N. D., Baranovskaya, O. I., Rizzino, A., & Tahirov, T. H. (2014) · Leukemia · doi:10.1038/leu.2014.111 · Cited by 51
“A 98 bp nucleotide sequence from minimal human TCRα enhancer (12-109)4 was cloned upstream to the SV40 promoter in pGL3-Basic vector (where the SV40 promoter is inserted upstream to Luciferase gene).”
MethodKopp, J. L., Wilder, P. J., Desler, M. M., Kim, J., Hou, J., Nowling, T. K., & Rizzino, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314115200 · Cited by 56
Inaba, H., Kuboniwa, M., Sugita, H., Lamont, R. J., & Amano, A. (2012) · Infection and Immunity · doi:10.1128/iai.00258-12 · Cited by 47
“This is consistent with reports showing that the p53 gene is transcriptionally regulated by Ets1 (3), and a deficiency of Ets1 decreases p53 expression level and reduces apoptosis induced by p53 in response to UV exposure (62).”
MethodCooper, C. D. O., Newman, J. A., & Gileadi, O. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130227 · Cited by 49
MMP3 at the crossroads: Linking molecular pathways to disease diagnosis and therapy
Jiang, J., Wu, Q., Rajasekaran, S., & Wu, R. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107750 · Cited by 46
Nagarajan, P., Parikh, N., Garrett‐Sinha, L. A., & Sinha, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004179 · Cited by 45
“Importantly, Ets1 is thought to regulate the expression of proteases such as urokinase plasminogen activator (uPA) and various members of the matrix metalloprotease family (MMP1, MMP2, MMP3, MMP9 and MMP13) [11,12,13,14,15,16].”
BackgroundPallai, R., Bhaskar, A., Sodi, V. L., & Rice, L. M. (2012) · Transcription · doi:10.4161/trns.22518 · Cited by 47
Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter
Baillat, D., Laitem, C., Leprivier, G., Margerin, C., & Aumercier, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.035 · Cited by 39
Self-citationStructural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA
Babayeva, N. D., Wilder, P. J., Shiina, M., Mino, K., Desler, M. M., Ogata, K., Rizzino, A., & Tahirov, T. H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12257 · Cited by 36
“The remaining fragment (301–441) was a minimal fragment exhibiting cooperative binding, albeit with significantly reduced cooperativity and a mixture of complexes with noncooperative Ets1 binding.(24) The data from the Aumercier laboratory also shows that phosphorylation of Ets1 significantly reduces, but does not eli…”
BackgroundMethodResultInfluentialMeckbach, C., Tacke, R., Hua, X., Waack, S., Wingender, E., & Gültaş, M. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0827-2 · Cited by 34
“Moreover, ETS1 is one of the well investigated transcription factors whose transcriptional activity is regulated by other factors by physical and functional interactions [41, 44, 45].”
BackgroundLegrand, A. J., Choul‐li, S., Spriet, C., Idziorek, T., Vicogne, D., Drobecq, H., Dantzer, F., Villeret, V., & Aumercier, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055883 · Cited by 35
Self-citationBaillat, D., Leprivier, G., Régnier, D., Vintonenko, N., Begue, A., Stéhelin, D., & Aumercier, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209583 · Cited by 29
“Similar behavior is observed in the case of the activation of the Stromelysin-1 promoter in response to Ets-1 or Ets-2 overexpression (Buttice and Kurkinen, 1993; Baillat et al., 2002).”
BackgroundMethodInfluentialSelf-citationEts1 as a marker of malignant potential in gastric carcinoma
Yu, Y. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i10.2154 · Cited by 29
Sui, H., Zhu, C., Li, Z., & Yang, J. (2020) · Oncology Reports · doi:10.3892/or.2020.7725 · Cited by 31
EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors
Florkowska, M., Tymoszuk, P., Balwierz, A., Skucha, A., Kochan, J. A., Wawro, M., Stalińska, K., & Kasza, A. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-8 · Cited by 29
“This type of interaction between proteins and DNA enhances the affinity of the second transcription factor, even to the sequence which is not canonical [33,34].”
BackgroundAgarkar, V. B., Babayeva, N. D., Wilder, P. J., Rizzino, A., & Tahirov, T. H. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.017 · Cited by 29
“Interestingly, the palindromic EBS on the stromelysin-1 and p53 promoters also facilitates the cooperative binding of Ets1 molecules, which results in synergistic activation of gene expression.(33,34) The binding of Elf3 to both the A- and the B-site is necessary for the synergistic activation of the mTβRII gene in F9…”
Kopp, J. L., Wilder, P. J., Desler, M. M., Kinarsky, L., & Rizzino, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609907200 · Cited by 30
Ets1 is an effector of protein kinase Cα in cancer cells
Vetter, M., Blumenthal, S. G., Lindemann, R. K., Manns, J., Wesselborg, S., Thomssen, C., & Dittmer, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208234 · Cited by 30
“Three genes (MMP1, MMP9, RUNX1) of the 32 PKCa- and Ets1-responsive genes have previously been shown to contain Ets binding sites and to be responsive to the Ets1 protein (Ghozi et al., 1996; Baillat et al., 2002).”
BackgroundHiguchi, T., Bartel, F. O., Masuya, M., Deguchi, T., Henderson, K. W., Li, R., Muise‐Helmericks, R. C., Kern, M. J., Watson, D. K., & Spyropoulos, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01871-06 · Cited by 29
“phage colony-stimulating factor, respectively (2, 35, 36).”
Shukla, A. A., Jain, M., & Chauhan, S. S. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07603.x · Cited by 24
Shiina, M., Hamada, K., Inoue-Bungo, T., Shimamura, M., Uchiyama, A., Baba, S., Sato, K., Yamamoto, M., & Ogata, K. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.020 · Cited by 29
“Luciferase reporter constructs were prepared by subcloning the minimal human TCRα enhancer (position 12–109) [16], the human mb-1 enhancer (position −525/+26) [50], and the human stromelysin-1 enhancer (position −478/+4) [51], upstream of the luciferase gene in the pGL3 basic vector (Promega).”
MethodDuval, D. L., Jean, A., & Gutierrez‐Hartmann, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302433200 · Cited by 24
Furumatsu, T., Matsumoto‐Ogawa, E., Tanaka, T., Lu, Z., & Ozaki, T. (2013) · Connective Tissue Research · doi:10.3109/03008207.2013.852544 · Cited by 22
“Expression of the secreted form of MMP-3 is modulated by several transcription factors, including nuclear factor-kB and ETS-1, a member of the E26 transformation-specific (ETS) family (4,5).”
BackgroundIdentification of ETS-1 target genes in human fibroblasts
Wernert, N. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.981 · Cited by 21
Martin, V., Zhuang, F., Zhang, Y., Pinheiro, K., & Gordân, R. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad872 · Cited by 20
Structural Basis of Ets1 Cooperative Binding to Widely Separated Sites on Promoter DNA
Babayeva, N. D., Baranovskaya, O. I., & Tahirov, T. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033698 · Cited by 23
“In the latter case, two Ets1 molecules were found to bind cooperatively to the palindromic sequences in which two head-to-head EBS were separated by four base pairs [27,28,29,30,31,32,33,34].”
BackgroundTranscriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells
Shen, X., Huang, L., Shao-hong, Z., Wang, D.-P., Wu, Y., Chen, W., Xu, S., & Lin, X. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.013 · Cited by 20
“effects, our results were consistent with previous findings that binding of two ETS-1 molecules to an EBS palindrome would form an ETS-1-DNA-ETS-1 ternary complex and facilitate gene regulation [19].”
ResultSearching for transcriptional regulators of Ang II-induced vascular pathology
Dzau, V. J., & Lopez-Ilasaca, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26384 · Cited by 21
Newman, J. A., Cooper, C. D. O., Aitkenhead, H., & Gileadi, O. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.619270 · Cited by 19
Role of Ets‐1 phosphorylation in the effector function of Th cells
Grenningloh, R., Miaw, S., Moisan, J., Graves, B. J., & Ho, I. (2008) · European Journal of Immunology · doi:10.1002/eji.200738112 · Cited by 22
Lionneton, F., Lelièvre, E., Baillat, D., Stehelin, D., & Soncin, F. (2003) · Oncogene · doi:10.1038/sj.onc.1207241 · Cited by 19
“Double-stranded biotinylated oligonucleotides (Opt; AGTCAGTCACGTACCGGAAGTGTGCAGTC, Opt[C 1G]; AGTCAGTCACGTACGGGAAGTGTGCAGTC), and their respective mutated counterparts serving as controls were immobilized on a streptavidin-coupled CM5 sensor chip (Baillat et al., 2002).”
MethodSelf-citationLiu, X., Zhang, C., Zhang, Z., Zhang, Z., Ji, W., Cao, S., Cai, X., Lei, D., & Pan, X. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2296 · Cited by 19
“16,17 Thus, studying the DNA-binding activity and transactivation potential or stability is essential.”
Vaughan, C. A., Deb, S. P., Deb, S., & Windle, B. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1708 · Cited by 20
“ETS1 binding to single or duplicate binding sites appears to be a mechanism of regulation of ETS1’s autoinhibition [27].”
BackgroundTranscription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury
Shiu, Y.-T. E., & Jaimes, E. A. (2018) · Antioxidants · doi:10.3390/antiox7070084 · Cited by 17
“It is important to note that, when two ETS DNA binding sites are present in the correct orientation and spacing, the autoinhibitory module of an ETS-1 protein can interact with the adjacent ETS-1 to relieve autoinhibitory function [25].”
BackgroundMultiple DNA-binding modes for the ETS family transcription factor PU.1
Esaki, S., Evich, M. G., Erlitzki, N., Germann, M. W., & Poon, G. M. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798207 · Cited by 20
Structural insights into transcription complexes
Berger, I., Blanco, A. G., Boelens, R., Cavarelli, J., Coll, M., Folkers, G. E., Nie, Y., Pogenberg, V., Schultz, P., Wilmanns, M., et al. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2011.04.015 · Cited by 16
“…Ets-1 on DNA response elements with a single ETS-binding site (EBS: 5 0 -GGA(A/T)-3 0 ) had not been observed for the stromelysin-1 promoter or the P53 promoter containing both two palindromic EBS separated by four base pairs (Venanzoni et al., 1996; Baillat et al., 2002; Baillat et al., 2009).”
Leprivier, G., Baillat, D., Begue, A., Hartmann, B., & Aumercier, M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp307 · Cited by 16
“Furthermore, our previous work demonstrated that the binding of Ets-1 to this EBS palindrome is essential for activating the Stromelysin-1 promoter and inducing protein expression in the cell (13,14).”
BackgroundMethodInfluentialSelf-citationDNA-dependent protein kinase is a novel interaction partner for Ets-1 isoforms
Choul‐li, S., Drobecq, H., & Aumercier, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.059 · Cited by 14
Self-citationLaitem, C., Choul‐li, S., Baillat, D., Begue, A., & Aumercier, M. (2008) · Protein Expression and Purification · doi:10.1016/j.pep.2008.06.010 · Cited by 13
Self-citationHahne, J. C., Fuchs, T., Haddouti, E.-M., Okuducu, A. F., Bories, J. C., & Wernert, N. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.1.153 · Cited by 13
“Previous studies investigating the roles of ETS-family members for transactivation or transrepression of protease genes have, in contrast, used co-transfection assays with maximal expression of the transcription factors in question (41,51,52).”
ETS1 Function in Leukemia and Lymphoma
Luchtel, R. A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_16 · Cited by 11
Kumari, S., Mallampati, S., Rana, M., Chatterjee, S., Aumercier, M., Mukhopadhyay, G., & Tyagi, R. K. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.020 · Cited by 12
Self-citationLegrand, A. J., Choul‐li, S., Villeret, V., & Aumercier, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713454 · Cited by 10
Self-citationKasahara, K., Shiina, M., Fukuda, I., Ogata, K., & Nakamura, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172654 · Cited by 12
“Another example is the promoter region of the stromelysin-1 gene, which is recognized by homo-dimerized Ets1 in the head-to-head configuration [11–13].”
Ets-1 interacts through a similar binding interface with Ku70 and Poly (ADP-Ribose) Polymerase-1
Choul‐li, S., Legrand, A. J., Bidon, B., Vicogne, D., Villeret, V., & Aumercier, M. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1484276 · Cited by 11
“1 p27 and N-terminal deletion mutant ΔN331 have been previously described [17,18].”
BackgroundMethodSelf-citationLin, H.-J., & Kodadek, T. J. (2005) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2005.00227.x · Cited by 9
Regulation of DYT1 gene expression by the Ets family of transcription factors
Armata, I. A., Ananthanarayanan, M., Balasubramaniyan, N., & Shashidharan, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05465.x · Cited by 8
“…promoters affects the relative position of a core sequence on the DNA turn as well as their relative distance along the DNA helix, resulting in decreased promoter activity in the majority of genes (Harvey et al. 1991; Baillat et al. 2002) and in fewer cases in increased activity (Spek et al. 1999).”
BackgroundPhoto-Induced Cross-Linking of Unmodified α-Synuclein Oligomers
Ortigosa-Pascual, L., Leiding, T., Linse, S. S., & Pálmadóttir, T. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00326 · Cited by 7
Couillard, J., Estève, P., Pradhan, S., & St‐Pierre, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25865 · Cited by 7
“Aumercier (Institut de Biologie de Lille, Institut Pasteur de Lille, Lille Cedex, France).(15) The expression vector encoding full-length c-Jun was a generous gift from Dr.”
BackgroundCaspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function
Choul‐li, S., Leroy, C., Leprivier, G., Laitem, C., Tulasne, D., & Aumercier, M. (2009) · Biochemical Journal · doi:10.1042/bj20090877 · Cited by 7
Self-citationA Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1
Samorodnitsky, D., Szyjka, C. E., & Koudelka, G. B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671339 · Cited by 7
“Consistent with this idea, ETS1 is also incapable of forming an EMSA-detectable complex with an MMP3 variant in which the two intact core consensus sequences are separated by an additional four bases (MMP3 4) (1).”
BackgroundMethodInfluentialMechanism of cognate sequence discrimination by the ETS-family transcription factor ETS-1
Huang, K., Xhani, S., Albrecht, A. V., Ha, V. L., Esaki, S., & Poon, G. M. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007866 · Cited by 5
Peacock, J., & Jaynes, J. B. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.07.024 · Cited by 5
Expression, purification, and structural prediction of the Ets transcription factor ERM
Mauën, S., Huvent, I., Raussens, V., Demonté, D., Baert, J., Tricot, C., Ruysschaert, J., Lint, C. M. V., Moguilevsky, N., & de Launoit, Y. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.03.007 · Cited by 5
“In competition experiments, the reactions contained a 12- to 144-fold molar excess of unlabeled double-stranded wild-type or Strom-M1M2 oligonucleotide (sense strand: 5′-ACCAAGACAAAAAGCACTTTTTGGAGATTA-3′) [21].”
BackgroundMethodInfluentialLiu, H. (2005) · DiVA at Umeå University (Umeå University) · Cited by 2
Ets-1 Protein Interactors in Transcriptional Activity Regulation
Choul‐li, S., & Aumercier, M. (2025) · Current Molecular Biology Reports · doi:10.1007/s40610-025-00165-4 · Cited by 1
“A limited number of promoters, including those of the stromelysin-1 matrix metalloprote-ase (MMP) [68, 69] and the p53 [70, 71] promoters, have been identified as containing such a configuration of EBSs.”
InfluentialSelf-citationRegulación de la expresión de genes en plantas por fotorreceptores
Batiller, R., & José, M. (2014)
Samorodnitsky, D., Szyjka, C. E., & Koudelka, G. B. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/070185
“Adding MMP3 + 4, a variant that separates the two EBSs present in MMP3 by an extra four bases (2), and to which ETS1Δ335 binds as a mix of monomers and dimers (data not shown) (14), also does not change the amount of dimer formed when compared to no DNA.”
BackgroundInfluentialBiologie moléculaire et structurale de complexes TFIID de l'homme
Nie, Y. (2012) · theses.fr (ABES) · doi:10.70675/6826f8b7z747cz4245z95acz3420257aa210
Meckbach, C. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7595
Fricke, M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1000
Mathialagan, M. (2008) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2008-07893
Mechanisms of action of ELF5 in breast cancer
Piggin, C. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3362
Legrand, A. J. (2013) · theses.fr (ABES) · doi:10.70675/e72a4ec9z687dz4a3cza0adzc5139347fddd · Cited by 1
“Dans ces conditions, le renforcement de la structure auto-inhibée de chaque molécule va à l’encontre de la levée mutuelle de l’auto-inhibition observée en absence de cette kinase [148].”
BackgroundInfluential
Metadata
- Authors
- Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Aumercier, Marc
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 277
- Issue
- 33
- Pages
- 29386-29398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971048234
- Cited by
- 84
- References
- 59
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 4
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6667 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Diffusion and Search Dynamics
- Keywords
- ETS1, stromelysin-1, matrix metalloproteinase-3, promoter transactivation, cooperative DNA binding, autoinhibition, transcription factor-DNA binding
- MeSH terms
- Base Sequence, Binding Sites, DNA, Genetic Vectors, Humans, Photochemistry, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcriptional Activation, Mutagenesis, Site-Directed, Matrix Metalloproteinase 3, Surface Plasmon Resonance, Electrophoretic Mobility Shift Assay, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.